Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL1400049	Exendin-4 Fc融合蛋白注射液	JY-09	Injection	Biological Products(1)	New Drug Application	2014-08-14	北京东方百泰生物科技有限公司	Beijing Dongfang Biotech Co Ltd	Certificate Issued	2016-04-21	view
CXSL1600061	重组人源化抗VEGF单克隆抗体注射液		Injection	Biological Products(2)	New Drug Application	2016-10-20	北京东方百泰生物科技有限公司	Beijing Dongfang Biotech Co Ltd	Certificate Issued	2017-05-22	view
CXSL1500087	重组人源化抗VEGF单克隆抗体注射液		Injection	Biological Products(2)	New Drug Application	2015-11-19	北京东方百泰生物科技有限公司	Beijing Dongfang Biotech Co Ltd	Certificate Issued	2017-01-23	view
CXSL1800023	重组抗VEGFR2全人源单克隆抗体（JY025）注射液	Recombinant anti-VEGFR2 human monoclonal antibody	Injection	Biological Products(1)	New Drug Application	2018-03-05	北京东方百泰生物科技有限公司	Beijing Dongfang Biotech Co Ltd	Certificate Issued	2018-07-24	view
CXSL1500023	重组抗肿瘤坏死因子-α全人源单克隆抗体注射液	adalimumab	Injection	Biological Products(2)	New Drug Application	2015-05-08	北京东方百泰生物科技有限公司	Beijing Dongfang Biotech Co Ltd	Certificate Issued	2017-02-13	view